- Home
- BEEP vs FBIO Comparison
BEEP vs FBIO Comparison
Compare BEEP & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEEP | FBIO |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | 101 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2M | 104.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BEEP | FBIO |
|---|---|---|
| Price | $2.27 | $2.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.50 | ★ $17.00 |
| AVG Volume (30 Days) | 26.1K | ★ 390.1K |
| Earning Date | 03-02-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,075,000.00 | N/A |
| Revenue This Year | $4.62 | $29.71 |
| Revenue Next Year | $21.28 | $49.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.26 | $1.33 |
| 52 Week High | $4.67 | $4.53 |
Technical Indicators
Market Signals| Indicator | BEEP | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 31.99 |
| Support Level | N/A | $2.42 |
| Resistance Level | $3.19 | $2.90 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 0.00 | 2.78 |
Price Performance
Historical ComparisonAbout BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.